Increasing incidence of diabetic population and adoption of self-monitoring devices are key factors driving market revenue growth
The global glucose biosensor market size was USD 10.20 Billion in 2021 and is expected to register a revenue CAGR of 7.9% over the forecast period, according to a latest report by Reports and Data. Increase in awareness about monitoring glucose levels is a key factor driving market revenue growth. Glucose biosensors are devices that measure concentration of glucose in diabetic patients by means of sensitive protein.
Obesity is majorly caused by unhealthy lifestyle accompanied by a lack of exercise and is found to be more associated with people having diabetes. According to Centre of Disease Control and Prevention (CDC), prevalence of diabetes among the U.S. population was 41.9%. Most people in the U.S. don't follow a healthy diet and consume excessive amount of sodium, saturated fat, and sugar, which increases their chance of developing diabetes. In the U.S., carbohydrates from food of lesser nutritional value, such as refined grains and cereals, added sugars, and potatoes, account for 42% of all calories ingested. However, only 9% of calories come from carbohydrates with higher nutritional value such as whole grains, fruits, legumes, and non-starchy vegetables.
Recent technological advancements and significant investments in research are also driving market revenue growth. For instance, on 8 July 2021, GBS Inc., which is a life science company developing non-invasive, real-time diagnostic testing for patients and health practitioners, received a funding of USD 4.7 million for setting up a biosensor manufacturing facility. The Australian Federal Government's Modern Manufacturing Initiative's Medical Products Priority Grant will help to develop a high-tech medical device manufacturing facility in Australia to start scaled production of printable organic electronic biosensor technology for the APAC region.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/5460
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Key companies profiled in the report include:
Abbott, Dexcom Inc., F. Hoffmann-La Roche Ltd., Sanofi, Bayer AG, GlySens Incorporated, Trividia Health, Inc., Medtronic, LifeScan, IP Holdings, LLC., and Senseonics.
Market Segmentation by Types:
Product Type Outlook (Revenue, USD Billion; 2019–2030)
- Continuous Glucose Monitoring (CGM)
- Self Monitoring Blood Glucose (SMBG)
Technology Type Outlook (Revenue, USD Billion; 2019–2030)
- Electrochemical
- Optical
- Piezoelectric
- Others
End-Use Outlook (Revenue, USD Billion; 2019–2030)
- Hospitals
- Homecare
- Diagnostic Centers
Order this Report @ https://www.reportsanddata.com/report-pricing/5460
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Glucose Biosensor market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Some Key Highlights From the Report
- On 11 March 2021, F. Hoffmann-La Roche Ltd., which is a Swiss multinational healthcare company introduced a new Accu-Chek Instant system, which supports and facilitates the company's integrated Personalized Diabetes Management strategy (iPDM). In addition, Bluetooth link between Accu-Chek Instant and mySugr application enables wireless uploading of blood glucose, resulting in mySugr app. Along with diabetes management tools, such as mySugr insulin calculator, this application provides users with rapid access to their diabetes data.
- The electrochemical segment accounted for largest revenue share in 2021 owing to their higher sensitivity, repeatability, ease of maintenance, and low cost. Electrochemical biosensors can be coupled with Labs-On-Chips (LOCs) to provide ideal Point-of-Care (POC) analytical platforms since they are practical, sensitive, and quick to react. These tools aid in early disease diagnosis and improve the likelihood of a patient's recovery. Electrochemical biosensors offer an appealing way to examine the content of a biological sample through direct conversion of a biological event to an electrical signal.
- The North America market accounted for largest revenue share in 2021. Significant investments in healthcare infrastructure and launch of new and innovative products are key factors driving market revenue growth. The U.S. market accounted for largest revenue share owing to presence of market companies such as Abbott, Dexcom, Inc., Medtronic, and many others. In addition, awareness programs launched by government in this country are significantly contributing to market revenue growth.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/5460
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.
Explore More Industry Research by Reports and Data:
Diabetic Ketoacidosis Market @ https://www.biospace.com/article/increase-in-the-prevalence-of-diabetes-and-insulin-therapy-is-expected-to-drive-diabetic-ketoacidosis-market-revenue-growth/
Autoimmune Hepatitis Market @ https://www.biospace.com/article/incidence-of-viral-disease-is-expected-to-drive-autoimmune-hepatitis-market-revenue-growth-by-2030/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
